US 10624887
Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diol
granted A61KA61K31/485A61K9/0053
Quick answer
US patent 10624887 (Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diol) held by Relmada Therapeutics, Inc. expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relmada Therapeutics, Inc.
- Grant date
- Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/485, A61K9/0053, A61K9/006, A61K9/1635